David A Ramsay insider trades

Open-market stock purchases and sales by David A Ramsay, EVP, PRESIDENT, DRUG DELIVERY at Halozyme Therapeutics, Inc, from SEC Form 4 filings since Jun 15, 2011.

Track record: 100% of 55 scored buys are up 5% or more since purchase, averaging +192%.

Recent trades

DateStockTradeValue
Jul 1, 2026HALO Halozyme Therapeutics, IncBought (not open market)—
Jul 1, 2026HALO Halozyme Therapeutics, IncBought (not open market)—
Jun 30, 2026HALO Halozyme Therapeutics, IncBought (not open market)—
Jun 30, 2026HALO Halozyme Therapeutics, IncSold (not open market)$423K
Jun 30, 2026HALO Halozyme Therapeutics, IncBought (not open market)—
Apr 1, 2026HALO Halozyme Therapeutics, IncBought (not open market)—
Dec 19, 2025SVRA Savara IncSold$121K
Dec 9, 2025SVRA Savara IncBought (not open market)—

Companies traded

  • HALO Halozyme Therapeutics, Inc: 1 buy, last Jul 1, 2026
  • SVRA Savara Inc: 68 buys, 1 sale, last Dec 19, 2025
  • LJPC LA Jolla Pharmaceutical Co: 28 buys, last Aug 22, 2022
  • MSTX Mast Therapeutics, Inc: other filings, last Jan 20, 2017
  • ANX Adventrx Pharmaceuticals Inc: 3 buys, last Jul 28, 2012

Get free alerts when David A Ramsay files a new trade →